Novartis announces the company’s fourth quarter and 2021 full year financial results.
February 02, 2022Access a digital and interactive version on the Annual Reporting microsit
“We’re building leadership positions in the platforms of the future to reimagine medicine for patients and lead this new era in health."
- Vas Narasimhan discussing how Novartis continues to grow with a pipeline of long-term innovation.$NVS $NOVN #NVSQ421— Novartis (@Novartis) February 2, 2022
Benefiting from our continued focus on innovation, Novartis has one of the industry’s most competitive pipelines.
Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies.
Disclaimer: The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the Novartis website for historical purposes only. Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
